- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07648394
Research on the Efficacy and Mechanism of Shouhui Tongbian Capsules in Treating Postoperative Constipation of Benign Anal and Rectal Diseases Based on Gut Microbiota Analysis
Study Title A study to learn how Shouhui Tongbian Capsules works to relieve constipation after anorectal surgery, and explore its effects linked to gut bacteria.
Why we do this study Constipation is a common problem after surgery for hemorrhoids, anal fistula and other benign anorectal diseases. It causes pain, slows wound healing and lowers quality of life. Traditional laxatives may lead to stomach pain, electrolyte problems and drug dependence.
Shouhui Tongbian Capsules is a traditional Chinese herbal medicine. It can ease constipation and protect the intestinal tract at the same time. This research aims to check how well this medicine works for post-surgery constipation, whether it reduces pain, and find out its working mechanism related to gut microbiota. We also want to collect evidence for better combined traditional Chinese and Western medicine treatment in clinic.
Who can take part Adults aged 18 to 75 who receive surgery for benign anorectal diseases and have constipation Fully aware of the study and willing to sign an informed consent form People with severe organ diseases, mental illness, cancer, bleeding disorders, pregnancy or other conditions will not be included.
How the study works
This is a prospective, randomized, controlled clinical trial. A total of 120 patients will be randomly divided into two groups (60 people each):
Test group: Take Shouhui Tongbian Capsules, 2 pills three times a day for 8 weeks.
Control group: Take lactulose oral solution, the common medicine for constipation.
We will assess symptoms regularly before, during and after treatment. We will record constipation severity, traditional Chinese medicine symptom scores, pain scores (VAS), quality of life (SF-36), physical signs and blood test results. We will also test gut bacteria and inflammation levels to analyze the medicine's mechanism.
Safety All participants will be closely monitored throughout the study. We will record any discomfort or side effects in a timely manner to ensure safety.
Expected benefits This study will confirm the effectiveness and safety of Shouhui Tongbian Capsules for post-anorectal surgery constipation. It may help relieve your constipation and post-operative pain, speed up recovery and improve daily life. The results will also help doctors choose better treatments for similar patients in the future.
Study timeline May - June 2026: Complete ethical review and study preparation July - September 2026: Recruit participants and start treatment Late 2026 - Early 2027: Finish data collection, analysis and paper writing
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Phase 2
- Phase 1
Kontakte und Standorte
Studienkontakt
- Name: Lihua Zheng
- Telefonnummer: 13366566578
- E-Mail: Zhenglihua0819@163.com
Studienorte
-
-
Chaoyang District
-
Beijing, Chaoyang District, China, 100029
- China-Japan Friendship Hospital
-
Kontakt:
- Lihua Zheng
- Telefonnummer: 13366566578
- E-Mail: Zhenglihua0819@163.com
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria: Age between 18 and 75 years old, male or female. Undergoing surgery for benign anorectal diseases (e.g., mixed hemorrhoids, anal fistula, anal fissure).
Meeting the diagnostic criteria for postoperative constipation (e.g., fewer than 3 spontaneous bowel movements per week, or difficulty in defecation).
Able to understand the study procedures and voluntarily sign the informed consent form.
Able to cooperate with medication administration, follow-up visits, and data collection.
Exclusion Criteria:Severe organic diseases of the heart, liver, kidney, or other vital organs.
History of inflammatory bowel disease, irritable bowel syndrome, or severe chronic constipation unrelated to surgery.
History of gastrointestinal surgery (other than the planned anorectal surgery) within the past 3 months.
Pregnancy, breastfeeding, or planned pregnancy during the study period (for female participants).
Known allergy or contraindication to the study drugs (Shouhui Tongbian Capsules or lactulose).
Current use of other laxatives, prokinetic drugs, or traditional Chinese medicine for constipation within 1 month before enrollment.
Severe mental disorders, cognitive impairment, or inability to communicate effectively.
Participation in other clinical trials within the past 3 months. Any other condition judged by the investigator to make the participant unsuitable for this study.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Shouhui Tongbian Capsules Treatment Group
|
Intervention DescriptionOral administration of Shouhui Tongbian Capsules (2 capsules, three times daily) combined with routine postoperative care for 8 consecutive weeks.
This patented Chinese herbal formula is designed to improve bowel function and relieve constipation in patients after benign anorectal surgery.
|
|
Aktiver Komparator: Lactulose Oral Solution Control Group
|
Oral administration of Lactulose Oral Solution (15 mL once daily) combined with routine postoperative care for 8 consecutive weeks.
This is a common osmotic laxative used to treat postoperative constipation in patients with benign anorectal diseases.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Change in Constipation Symptom Score from Baseline to Week 8
Zeitfenster: Baseline and Week 8
|
Baseline and Week 8
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2026-KY-178-1
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Shouhui Tongbian Capsules
-
Shandong UniversityShandong Public Health Clinical CenterNoch keine Rekrutierung
-
Shanghai General Hospital, Shanghai Jiao Tong University...Noch keine Rekrutierung
-
First Teaching Hospital of Tianjin University of...Noch keine Rekrutierung
-
University of Medicine and Pharmacy at Ho Chi Minh...RekrutierungGesund | Magen-Darm-MotilitätVietnam